CDKL5 Deficiency Disorder: CDKL5 Deficiency Disorder (CDD) is a rare brain disorder caused by a mutation in the CDKL5 gene (cyclin-dependent kinase-like 5), which is located on the X chromosome. Most children affected by CDD suffer from seizures that begin in the first few months of life and are unable to walk, talk, or feed themselves. Other symptoms of CDD include cognitive delays, difficulties in communication, behavioral issues, cortical visual impairments, sleep disturbance, and gastrointestinal issues. Currently, no therapies exist for CDD, and only symptomatic pharmacological treatments are available.

Meeting Mission: The meeting will be face-to-face, aiming to bring together scientists, clinicians, and pharmaceutical companies from around the world, particularly the Asia-Pacific Region, working on CDD and relevant neurodevelopmental disorders, along with representatives from patient organizations and CDD families, to meet and discuss the latest developments in the field and advance towards treatments and cures. This is a unique opportunity for parents and professionals to come together, hear the latest in research and clinical trials, and learn the most current recommended care and advocacy strategies for every stage of life.

Registration link : https://cloud.itsc.cuhk.edu.hk/webform/view.php?id=13714989
Welcome to join us!